Musaffa Logo

Our certifications

Independent proof that every stock and portfolio meets halal standards.

How we screen every stock
METHODOLOGY

How we screen every stock

Our 5-step halal methodology, in 90 seconds.

ACUT Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: April 10, 2025

Report Source: 2024 Annual Report

Accustem Sciences Inc

Accustem Sciences Inc. Stock Analysis ACUT

United States Health Care Nano Cap Report:
AccuStem Sciences, Inc. is a clinical stage diagnostics company, which engages in medical practice activities. The company is headquartered in New York City, New York and currently employs 4 full-time employees. The company went IPO on 2022-03-01. The company is focused on developing and commercializing a suite of genomic tests that support decision-making along the entire continuum of oncology care. The company focuses on its proprietary genomic tests, MicroRNA Signature Classifier (MSC) for patients with lung nodules and StemPrintER for patients with early-stage breast cancer. The MSC test, a 24-micro-RNA (miRNA) assay designed to help determine whether lung nodules identified by low-dose computer tomography (LDCT) screening, are benign or malignant. StemPrintER, a 20-gene prognostic assay intended to predict the risk of distant recurrence (DR) in luminal (ER+/HER2-negative) breast cancer patients. The assay is developed to measure the stemness of tumors, or how much a tumor behaves like stem cells, which could indicate how likely a cancer is to recur or be resistant to standard treatments, ultimately impacting how patients are managed by their multidisciplinary care team.
Read More

Accustem Sciences Inc (ACUT) Chart

Key Statistics of Accustem Sciences Inc (ACUT)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$0.21$0.23

Today's Open

$0.22

Volume

4574.00

P/E Ratio (TTM)

-

52 Week Range

$0.21$2.33

Market Cap

4.34M

Avg. Volume

2783.00

Dividend Yield

-

Financial Metrics & Statements of Accustem Sciences Inc (ACUT)

FAQ's for Accustem Sciences Inc (ACUT)

  • According to Musaffa’s Shariah screening methodology, Accustem Sciences Inc (ACUT) is currently classified as NOT HALAL as of April 2025. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.
  • A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Accustem Sciences Inc using these criteria to determine its compliance status.
  • Muslim investors may consider investing in Accustem Sciences Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
  • Musaffa determines the Shariah status of Accustem Sciences Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
  • The Shariah compliance status of Accustem Sciences Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
  • Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
  • You can check the latest Shariah compliance status of Accustem Sciences Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Disclaimer

The content provided on this website is intended solely for informational and educational purposes. Musaffa is a technology, data, education, and research company. We are not licensed financial service provider by the authorized relevant financial service regulator in India or any other regulatory government body, and we do not offer or facilitate any trading, brokerage, investment, or financial advisory services. We do not deliberately target an audience seeking financial services.

By accessing this website, you acknowledge and confirm that you are seeking information relating to Musaffa of your own accord, and that there has been no form of solicitation, advertisement, or inducement by Musaffa or its members. Musaffa shall not be liable for the consequences of any action taken by relying on the material or information provided on this website. The contents of this website are the intellectual property of Musaffa.